CS
Chetan Sureshchandra Mehta
About Chetan Sureshchandra Mehta
Data last updated:
Chetan Sureshchandra Mehta is a Director at Mehta Antibiotics Private Limited (since 2011). The companies operate in Pharma. Mehta Antibiotics Private Limited reported revenue of ₹3.8 Lakh (FY 2025). Earlier, Chetan Sureshchandra Mehta was a Director at Mehta Api Private Limited (2001–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2011 | 2011 | ₹3.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jan 2001 | 1987 | ₹326 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chetan Sureshchandra Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atul Sureshchandra Mehta | 01558289 | Mehta Antibiotics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetan Sureshchandra Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetan Sureshchandra Mehta
Chetan Sureshchandra Mehta currently holds 1 directorship: Mehta Antibiotics Private Limited (Director, since 01 Mar 2011, revenue ₹3.8 Lakh (FY 2025)).
Chetan Sureshchandra Mehta was first appointed on 01 Jan 2001 as Director at Mehta Api Private Limited. The most recent appointment on record is 01 Mar 2011 at Mehta Antibiotics Private Limited.
Chetan Sureshchandra Mehta held 1 earlier board appointment: Mehta Api Private Limited (Director, 01 Jan 2001 to 31 Dec 2010).
The current boards of Chetan Sureshchandra Mehta's companies include Atul Sureshchandra Mehta (Mehta Antibiotics Private Limited).